Author:
Delavenne Xavier,Moracchini Julie,Laporte Silvy,Mismetti Patrick,Basset Thierry
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference13 articles.
1. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial;Eriksson;Journal of Thrombosis and Haemostasis,2005
2. Randomized evaluation of long-term anticoagulation therapy, newly identified events in the RE-LY trial;Connolly;The New England Journal of Medicine,2010
3. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects;Stangier;British Journal of Clinical Pharmacology,2007
4. New oral antithrombotics: a need for laboratory monitoring. Against;Bounameaux;Journal of Thrombosis and Haemostasis,2010
5. EMEA, CHMP assessment report for Pradaxa, 2008.
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献